Viewing nowJanuglycia 100 mg (Sitagliptin hydrochloride monohydrate)
Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

MFDS item code 202100851 · Approved 2021.01.28 · Insurance code 653806120
Improvement of glycemic control in type 2 diabetes mellitus
This drug is used in conjunction with diet and exercise therapy to help control blood sugar in patients with type 2 diabetes. It can be used alone but can also be combined with metformin at the initiation of treatment. Additionally, it can be used as an adjunct when other diabetes medications, such as sulfonylureas, thiazolidinediones, or insulin, are not sufficient for blood sugar control. Depending on the situation, it helps in enhancing blood sugar control effectiveness by combining various medications. This drug allows for more effective management of blood sugar levels.
When used as monotherapy or combination therapy, administer 100 mg once daily; the maximum daily dose is 100 mg. This medication may be taken with or without food. When administered concomitantly with a sulfonylurea or insulin, consider reducing the dose of the sulfonylurea or insulin to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General precautions). Because dose adjustment is required according to renal function, assessment of renal function is recommended before and periodically during treatment with this medication. 1. No dose adjustment is required in patients with mild renal impairment (eGFR ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (eGFR ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. In patients with moderate renal impairment (eGFR ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. In patients with severe renal impairment (eGFR ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (eGFR < 15 mL/min/1.73 m2), administer 25 mg once daily. This medication may be administered without regard to the timing of dialysis.
This drug may cause severe allergic reactions, so if symptoms such as skin rash or difficulty breathing occur, you must stop taking it immediately and consult a physician. There is a risk of acute pancreatitis occurring during treatment, so symptoms such as abdominal pain, vomiting, or loss of appetite should be monitored closely. Patients with type 1 diabetes or diabetic ketoacidosis should not take this medication. Those allergic to this drug or its ingredients should not take it. Patients with decreased kidney function need to adjust the dosage of this medication, and regular kidney function tests are important. Symptoms similar to a cold, headaches, diarrhea, nausea, etc. may occur during treatment. When combined with insulin or sulfonylureas, there is an increased risk of hypoglycemia, so blood sugar changes should be monitored closely and drug dosages adjusted as necessary. This drug may cause rare side effects such as severe joint pain or blistering skin diseases, so inform your doctor immediately if joint pain or skin abnormalities occur. Use of this drug is not recommended for pregnant or lactating women. In case of overdose, you should visit a medical institution immediately for appropriate treatment, and this drug can be partially removed via dialysis. This drug has fewer drug interactions, but it is advisable to consult with a physician or pharmacist when taking it with specific medications. Elderly patients may have decreased kidney function, so kidney function tests should be performed before taking this medication, and dosage adjustments may be necessary.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air exposure, and it is best to store it at room temperature between 1 degree and 30 degrees Celsius. This storage method helps maintain the drug's efficacy and prevents degradation.
Light brown, round, biconvex film-coated tablet
PTP - 28 tablets/box [(14 tablets/PTP×2)], bottle - 30 tablets/bottle, bottle - 90 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.